儿童神经母细胞瘤患者放疗后肾周间隙持续假阳性18F-MFBG摄取
本病例报告描述一名儿童神经母细胞瘤患者在接受化疗、手术和放疗后,行18F-MFBG PET/CT评估疗效时发现右侧肾周间隙摄取增高,对应CT见云絮状阴影,且位于放疗野内;随访复查该病灶持续阳性,结合病史考虑为放疗相关持续性假阳性摄取,提示鉴别诊断时应予考虑。
要点
- 儿童神经母细胞瘤治疗后18F-MFBG PET/CT评估中,放疗野内肾周间隙可出现持续性假阳性摄取。
- 该摄取对应CT云絮状阴影,随访持续阳性,结合病史考虑与既往放疗相关。
- 解读18F-MFBG PET/CT时,应将放疗相关假阳性摄取纳入鉴别诊断。
核心结论
- 儿童神经母细胞瘤患者放疗后肾周间隙的持续性18F-MFBG摄取应考虑为放疗相关假阳性,并在鉴别诊断中予以考虑。
研究设计与样本
- 病例报告:一名儿童神经母细胞瘤患者在接受化疗、手术和放疗后行18F-MFBG PET/CT评估治疗反应,并进行后续随访18F-MFBG PET/CT成像。
主要发现
- 18F-MFBG PET/CT显示右侧肾周间隙18F-MFBG积聚增高,对应CT图像上见云絮状阴影,且位于放疗野内。
- 后续随访18F-MFBG PET/CT成像中该病灶持续为阳性。
- 基于临床病史,该持续性18F-MFBG摄取被认为与既往放疗相关。
临床怎么用
- 在儿童神经母细胞瘤患者放疗后解读18F-MFBG PET/CT时,若放疗野内出现肾周间隙持续性摄取增高伴CT云絮状阴影,应结合放疗病史考虑放疗相关假阳性可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An 18F-MFBG PET/CT scan was conducted to evaluate the therapeutic response following treatment with chemotherapy, surgery, and radiotherapy. This study demonstrated increased 18F-MFBG accumulation in the right perirenal space, accompanied by a cloud-like shadow on the corresponding CT images, which was within the radiation therapy field. The lesion remained positive on subsequent follow-up 18F-MFBG PET/CT imaging. This abnormal MFBG accumulation was within the radiation therapy field. Based on the clinical history, this persistent 18F-MFBG uptake was considered to be related to prior radiotherapy, and should be considered in the differential diagnosis.
引用
- Zhang K, Ma Y, Wang X, et al. Radiation-induced Continuous False-positive 18F-MFBG Uptake in the Perirenal Space of a Pediatric Neuroblastoma Patient. Clin Nucl Med. 2026. PMID: 42377402. doi:10.1097/RLU.0000000000006599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。